远程细胞学辅助快速现场评估的质量保证研究
该研究回顾性分析了某高容量癌症中心7年间远程细胞学辅助快速现场评估(ROSE)的病例,聚焦细针穿刺和粗针活检触片。结果显示平均NDIS率为0.06%(42/70,612),主要原因为将良性或反应性细胞误判为肿瘤性(76.2%)。肾脏活检NDIS率最高(0.90%),甲状腺活检与定量阈值问题相关(0.10%)。
要点
- 远程细胞学辅助ROSE的NDIS率低(0.06%),但需质量保证。
- 误判良性/反应性细胞为肿瘤性是主要 discrepancy 原因(76.2%)。
- 肾脏活检NDIS率最高(0.90%),需注意部位特异性陷阱。
核心结论
- 远程细胞学辅助ROSE的NDIS率低,但质量保证识别了改进领域。
- 识别部位特异性陷阱可提高诊断准确性并优化患者管理。
研究设计与样本
- 回顾性分析7年间某高容量癌症中心的远程细胞学辅助ROSE病例,聚焦细针穿刺和粗针活检触片。
- 每例均结合临床数据及同期粗针活检或后续切除进行复核,识别导致NDIS的主要因素。
主要发现
- 平均NDIS率为0.06%(42/70,612)。
- 将良性或反应性细胞误判为肿瘤性是ROSE与最终诊断不一致的主要原因(76.2%)。
- 肾脏活检NDIS率最高(0.90%),主要因误判非肿瘤性细胞。
- 甲状腺活检与定量阈值问题相关(0.10%)。
- NDIS事件最常与肾脏、胰腺、胃肠道和肺活检的误判相关。
临床怎么用
- 远程细胞学辅助ROSE可用于细针穿刺和粗针活检触片的快速评估。
- 应关注肾脏、胰腺、胃肠道和肺活检中误判良性/反应性细胞为肿瘤性的风险。
- 甲状腺活检需注意定量阈值问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Telecytology-assisted rapid on-site evaluation (ROSE) offers a cost-effective method to enhance minimally invasive biopsies like fine needle aspiration and core biopsies with touch preparation. By reducing nondiagnostic sampling and the need for repeat procedures, ROSE via telecytology facilitates prompt triage for ancillary tests, improving patient management. This study examines cases initially deemed adequate for diagnosis during telecytology-assisted ROSE but later categorized as nondiagnostic at final evaluation (NDIS). DESIGN: We performed a retrospective analysis of telecytology-assisted ROSE cases over 7 years at a major cancer center, focusing on fine needle aspiration and touch preparation of core biopsies. Each case was thoroughly reviewed, correlating with clinical data and concurrent core biopsies or subsequent excisions. The study identified leading factors contributing to NDIS. RESULTS: The average NDIS rate was 0.06% (42/70,612). Misinterpretation of benign or reactive cells as neoplastic was the leading cause (76.2%) of discrepancies between original ROSE and final diagnosis. Kidney biopsies had the highest NDIS rate (0.90%), primarily because of misinterpreting nonneoplastic cells. Thyroid biopsies were linked to quantitative threshold issues (0.10%). NDIS events were most associated with misinterpretation in kidney, pancreas, gastrointestinal tract, and lung biopsies. CONCLUSION: In conclusion, the NDIS rate in telecytology-assisted ROSE is low, but quality assurance identified areas for improvement. Recognizing site-specific pitfalls during telecytology-assisted ROSE can enhance diagnostic accuracy and optimize patient care.
引用
- Alhamar M, Rudomina D, Wang L, et al. Rapid on-site evaluation using telecytology: Quality assurance study at a high-volume cancer center. Cancer Cytopathol. 2025. PMID: 39745134. doi:10.1002/cncy.22929
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。